Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9M Buy
42,901
+32,354
+307% +$8.13M 0.01% 789
2025
Q4
$3M Buy
10,547
+275
+3% +$86K ﹤0.01% 1277
2025
Q3
$3.17M Buy
10,272
+1,245
+14% +$390K ﹤0.01% 1159
2025
Q2
$2.84M Buy
9,027
+904
+11% +$261K ﹤0.01% 1131
2025
Q1
$2.13M Buy
8,123
+1,396
+21% +$378K ﹤0.01% 1201
2024
Q4
$1.76M Buy
6,727
+505
+8% +$127K ﹤0.01% 1293
2024
Q3
$1.45M Buy
6,222
+423
+7% +$86.9K ﹤0.01% 1368
2024
Q2
$1.17M Buy
5,799
+1,424
+33% +$257K ﹤0.01% 1411
2024
Q1
$750K Buy
4,375
+130
+3% +$24.2K ﹤0.01% 1723
2023
Q4
$921K Buy
4,245
+2,173
+105% +$373K ﹤0.01% 1488
2023
Q3
$330K Sell
2,072
-662
-24% -$148K ﹤0.01% 2076
2023
Q2
$788K Buy
2,734
+39
+1% +$11.8K ﹤0.01% 1449
2023
Q1
$859K Buy
2,695
+25
+0.9% +$7.41K ﹤0.01% 1360
2022
Q4
$786K Buy
2,670
+599
+29% +$165K ﹤0.01% 1363
2022
Q3
$475K Buy
+2,071
New +$519K ﹤0.01% 1455

Other funds holding PODD

Mariner's PODD Position: Q1 2026 in Review

Mariner increased its Insulet (PODD) stake by 307% in Q1 2026, buying an estimated $8.13M and bringing the position to 42,901 shares worth $9M. The position accounts for 0.01% of the portfolio, ranked #789.

Mariner first reported a position in PODD in Q3 2022 and has held it in 15 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Mariner held 42,901 shares of Insulet worth $9M as of Q1 2026.
  • Mariner bought 32,354 Insulet shares in Q1 2026, an estimated $8.13M.
  • Insulet made up 0.01% of Mariner's portfolio in Q1 2026, its #789 holding.
  • Mariner first reported a position in Insulet in Q3 2022 and has held it in 15 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.